Stockreport

Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approvalThis historic approval of the world's first Self-Amplifying messenger RNA (sa-mRNA) COVID-19 V [Read more]